These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26997620)

  • 1. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
    Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
    J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β
    Nagatomo Y; McNamara DM; Alexis JD; Cooper LT; Dec GW; Pauly DF; Sheppard R; Starling RC; Tang WH;
    J Am Coll Cardiol; 2017 Feb; 69(8):968-977. PubMed ID: 28231950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β
    Kawai A; Nagatomo Y; Yukino-Iwashita M; Nakazawa R; Taruoka A; Yumita Y; Takefuji A; Yasuda R; Toya T; Ikegami Y; Masaki N; Ido Y; Adachi T
    J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling.
    Mohan ML; Nagatomo Y; Saha PP; Mukherjee SD; Engelman T; Morales R; Hazen SL; Tang WHW; Naga Prasad SV
    Mol Biol Cell; 2021 Apr; 32(7):622-633. PubMed ID: 33534612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study.
    Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M;
    J Card Fail; 2015 Mar; 21(3):198-207. PubMed ID: 25528200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease.
    Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F
    Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function.
    Michelucci A; D'Elios MM; Sticchi E; Pieragnoli P; Ricciardi G; Fatini C; Benagiano M; Niccolai E; Grassi A; Attanà P; Nesti M; Grifoni G; Padeletti L; Abbate R; Prisco D
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):65-72. PubMed ID: 26411359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.
    Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Baba A; Anzai T; Meguro T; Satoh T; Ogawa S
    J Card Fail; 2009 Apr; 15(3):224-32. PubMed ID: 19327624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of autoantibodies against β1-adrenoceptor and cardiac troponin-I for clinical outcomes in STEMI.
    Fan Y; Chen Y; Wan Z; Zhou D; Ma A
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18(1):34-41. PubMed ID: 26258721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M; Wallukat G; Potapov E; Hetzer R
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
    Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
    Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
    Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
    Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
    Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.
    Sun R; Mak S; Haschemi J; Horn P; Boege F; Luppa PB
    J Appl Lab Med; 2019 Nov; 4(3):391-403. PubMed ID: 31659076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy.
    Wess G; Wallukat G; Fritscher A; Becker NP; Wenzel K; Müller J; Schimke I
    PLoS One; 2019; 14(7):e0214263. PubMed ID: 31276517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The β
    Patel JK
    J Am Coll Cardiol; 2017 Feb; 69(8):978-980. PubMed ID: 28231951
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody.
    Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M
    Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies in heart failure.
    Cao N; Chen H; Bai Y; Yang X; Xu W; Hao W; Zhou Y; Chai J; Wu Y; Wang Z; Yin X; Wang L; Wang W; Liu H; Fu MLX
    Cardiovasc Res; 2018 Sep; 114(11):1487-1498. PubMed ID: 29746700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.